| Tour |
Match |
Score |
Plc |
IC |
ADV |
Top |
Pts |
% |
ic |
adv |
plc |
nég |
% |
| 1
| CINa-PHEb |
47.0-31.0 |
16 |
0.0 |
8.0 |
901 |
-450
|
50.06 |
|
x
|
|
x
|
|
x
|
|
x
|
|
x
|
| 2
| PHEb-KIHb |
41.5-36.5 |
15 |
0.0 |
7.0 |
1055 |
-448
|
57.54 |
|
x
|
|
|
|
|
|
|
|
|
| 3
| NUPa-PHEb |
40.0-38.0 |
16 |
0.0 |
8.0 |
851 |
-256
|
69.92 |
|
x
|
|
x
|
|
x
|
|
|
|
|
| 4
| PHEb-KIHa |
23.0-55.0 |
16 |
0.0 |
8.0 |
749 |
-271
|
63.82 |
|
x
|
|
x
|
|
x
|
|
|
|
|
| 5
| ACJc-PHEb |
49.0-29.0 |
14 |
0.0 |
7.0 |
848 |
-249
|
70.64 |
|
x
|
|
|
|
|
x
|
|
x
|
|
| 6
| PHEb-CINa |
25.0-53.0 |
16 |
0.0 |
8.0 |
949 |
-381
|
59.85 |
|
x
|
|
x
|
|
x
|
|
|
|
|
| 7
| KIHb-PHEb |
42.0-36.0 |
16 |
0.0 |
8.0 |
938 |
-397
|
57.68 |
|
x
|
|
x
|
|
x
|
|
|
|
|
| 8
| PHEb-NUPa |
38.0-40.0 |
14 |
1.0 |
8.0 |
914 |
-282
|
69.15 |
x
|
|
|
x
|
|
|
|
|
|
|
| 9
| KIHa-PHEb |
54.0-24.0 |
14 |
1.0 |
8.0 |
865 |
-265
|
69.36 |
x
|
|
|
x
|
|
|
|
|
|
|
| 10
| PHEb-ACJc |
27.0-51.0 |
12 |
1.0 |
6.0 |
835 |
-262
|
68.62 |
x
|
|
x
|
|
x
|
|
|
|
|
|